Even if the technology is high performing, the technology will not pass the inflection point if there is little public attention and if companies won’t invest, resulting in few complements.
Image: Shutterstock
In 2019, few people talked about messenger ribonucleic acid, or what is commonly known as mRNA. But by the fall of 2020, this acronym was all over the news because it enabled quick production of vaccines to fight Covid-19. Similarly, in the summer of 2022, few people knew what Generative AI (GenAI) meant. Yet the launch of ChatGPT in November made everyone aware of this technology’s immense opportunities.
[This article is republished courtesy of INSEAD Knowledge
http://knowledge.insead.edu, the portal to the latest business insights and views of The Business School of the World. Copyright INSEAD 2023]